Johnson & Johnson's Vision Care division saw revenues jump by 6.2 percent in the third quarter. The management said that the contact lens business continued to grow above market trends on the strength of the astigmatism and daily disposable lenses in the Oasys family. In Vision Surgical, the company's global growth of 4.1 percent was driven by higher international sales of intraocular lenses for cataracts.

Worldwide, sales of medical devices declined by 0.2 percent to $6.6 billion, with an operational increase of 1.7 percent and a negative currency impact of 1.9 percent. Domestic sales improved by 0.3 percent, while international sales decreased by 0.6 percent.

Overall, the Johnson & Johnson group's revenues were up by 3.6 percent to $20,348 million in the quarter. The company's gross margin advanced by 2.8 percentage points to 67.6 percent. Net income rose by 4.5 percent to $3,934 million.

The management said in a conference call that it is preparing for the launch of a contact lens that will automatically adjust from outdoor to indoor light.